|
WO2012013816A1
|
|
Compounds and methods for treating neoplasia
|
|
WO2010149666A1
|
|
Methods for treating neoplasia
|
|
CN101460846A
|
|
Detection of membrane androgen receptor (mar) agents
|
|
US2009104122A1
|
|
DETECTION OF MEMBRANE ANDROGEN RECEPTOR (mAR) AGENTS
|
|
AU2006281569A1
|
|
Composition and method for determination of CK19 expression
|
|
CN101365800A
|
|
Composition and method for determination of CK19 expression
|
|
WO2005009460A2
|
|
Pharmaceutical composition comprising activin a, alk-4 or derivatives thereof for the treatment of ophthalmic disorders or cancer
|
|
BR0312690A
|
|
Steroid conjugates, their preparation and their use
|
|
WO2004006966A1
|
|
Steroid conjugates, preparation thereof and the use thereof
|
|
AU1166201A
|
|
Pharmaceutical formulations comprising labdanes for the treatment of tumors or leukemias
|
|
EP1253909A2
|
|
Pharmaceutical formulations comprising labdanes for the treatment of tumors or leukemias
|
